SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently trending due to a significant surge following a strong earnings report that beat expectations, fueling community debate over whether the stock is a long-term turnaround play or an overextended bubble prone to a sharp reversal. Investors are actively discussing the potential for a massive short squeeze and debating the impact of government-backed foundry strategies as the stock tests multi-year highs.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD shares are rallying in sympathy with Intel's strong earnings results, as investors express renewed confidence in the broader AI-driven CPU demand cycle. The community is actively debating the stock's parabolic trajectory and aggressive analyst upgrades, with many bullish traders focused on long-term data center growth while skeptical bears highlight concerns over overvaluation.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is experiencing significant volatility and intense community debate, driven by a mixture of speculation regarding potential OpenAI partnerships and concerns over institutional audits. While some investors are aggressively averaging down following the CEO's substantial insider purchase, others remain skeptical, citing persistent underperformance compared to the broader software sector and a lack of official catalysts before the upcoming earnings report.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares (SOXS) is trending as traders grapple with the relentless, parabolic rise of the semiconductor sector, which has sparked intense debate over whether the market is in a historic bubble or a durable super-cycle. The community is deeply divided between those aggressively betting on a violent mean reversion through short positions and others who warn that extreme volatility decay and the structural mechanics of leveraged ETFs make this a dangerous tool for anything other than short-term tactical trades.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is seeing explosive, near-parabolic growth as investors chase a semiconductor super-cycle driven by intense AI-related demand, fueling a massive short squeeze that has left many bears reeling. The community is sharply divided between those betting on an imminent blow-off top and bubble pop, and momentum traders who argue that unprecedented sector demand and institutional inflows justify continuing the aggressive rally.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

VanEck Semiconductor ETF is experiencing intense volatility and record-breaking momentum, with community debate centered on whether the sector is undergoing a sustainable AI-driven secular expansion or inflating into a historical bubble similar to the dot-com era. Traders are actively monitoring circular AI financing and supply chain constraints, while the community remains sharply divided between those riding the parabolic trend and others bracing for a significant, liquidity-driven correction.

Skillz, Inc. operates a mobile gaming platform that connects players in competition. It helps developers build franchises by enabling social competition in their games. Skillz hosts casual esports tournaments for mobile players worldwide. The company was founded by Andrew C Paradise and Casey Chafkin in 2012 and is headquartered in Las Vegas, NV.

Skillz Inc - Ordinary Shares - Class A

Skillz Inc

Skillz Inc. is experiencing significant market volatility and high trading volume following a major jury verdict that awarded the company hundreds of millions in damages over deceptive advertising practices by a competitor. The community is actively debating the stock's future, weighing the potential for a massive short squeeze against concerns over the timeline for legal payouts and long-term business fundamentals.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is currently trending due to a major strategic partnership with OpenAI, which aims to accelerate drug discovery and optimize operational efficiency, alongside recent positive regulatory and data developments for its GLP-1 portfolio. The community remains focused on the company's valuation gap compared to its primary competitor, Eli Lilly, while actively debating the long-term impact of its oral Wegovy pipeline versus emerging rival therapies.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is currently a major focus for investors as they monitor the stock's consolidation phase against the broader semiconductor sector, with community discourse centered on whether it remains the primary leader in AI infrastructure or if rotation into other chip makers is accelerating. Investors are actively tracking the stock's stability near support levels and analyzing recent strategic partnerships, such as those in the energy and nuclear sectors, as potential catalysts for future performance.

MaxLinear, Inc. engages in the provision of communications systems-on-chip (SoC) solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. Its products include cable broadband modems and gateways, wireline connectivity devices, radio frequency transceivers, fiber-optic modules, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products. The company was founded by Kimihiko Imura, Curtis C. Ling, and Kishore V. Seendripu on September 25, 2003 and is headquartered in Carlsbad, CA.

MaxLinear Inc

MaxLinear is currently trending after reporting strong Q1 earnings that beat analyst estimates and provided above-consensus guidance, signaling an inflection point in its data center infrastructure business. The community is actively discussing the stock's significant pre-market rally, the company's positioning as a key player in AI infrastructure, and the potential for share price re-rating following these positive developments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Strength Seen in Catalyst (CPRX): Can Its 6.7% Jump Turn into More Strength?

Catalyst (CPRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Catalyst Pharmaceuticals (NASDAQ:CPRX) Sets New 1-Year High - Here's What Happened

Catalyst Pharmaceuticals (NASDAQ:CPRX) Reaches New 52-Week High - What's Next...

SNY & REGN's Dupixent Wins FDA Nod for Pediatric Use in Urticaria 

Sanofi wins FDA nod to expand Dupixent in kids aged 2-11 years, marking the first biologic for young patients with uncontrolled CSU.

SNY's Tzield Gets FDA Nod for Kids, Sarclisa SC BLA Faces Delay

Sanofi wins FDA nod to expand Tzield's use to younger patients, while Sarclisa SC review faces delay with a new decision date set for July 2026.

INBX Stock Up on Upbeat Clinical Update From Colorectal Cancer Study

Inhibrx Biosciences stock surges after phase I/II CRC data of ozekibart show strong response rates and durable benefit, alongside a new FDA filing for ozekibart in chondrosarcoma.

AMRX Announces Kashiv BioSciences Buyout, Solid Q1 Preliminary Results

Amneal's deal to buy Kashiv for up to $1.10B aids biosimilar push. The company posts strong preliminary Q1 results and raises 2026 EPS guidance.

European Commission Approves MRNA's COVID-19-Influenza Combo Shot

Moderna wins EU approval for its COVID-19-flu combo shot mCombriax, backed by strong phase III data showing superior immune response vs standalone vaccines.

NVO's Etavopivat Hits Key Goals in Phase III Sickle Cell Disease Study

Novo Nordisk's etavopivat meets phase III goals, cutting VOCs and boosting haemoglobin in sickle cell disease, with data backing a favorable safety profile.

LLY to Buy Oncology Biotech Kelonia Therapeutics for $7 Billion

Eli Lilly is set to acquire Kelonia Therapeutics in a $7B deal, boosting its genetic medicine platform with a novel in vivo CAR-T therapy for cancer.

Agios Stock Sinks 23% as NVO's PKR Activator Meets Goal in SCD Study

AGIO shares plunge after Novo Nordisk's strong sickle cell data raised doubts about mitapivat's competitiveness and approval prospects.

Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E. Huckel and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.

CPRX
Catalyst Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CPRX News

CPRXCatalyst Pharmaceuticals Inc